Myriad Genetics News, Myriad Genetics Quote, MYGN Quote

Myriad Genetics (NQ:MYGN) Delayed: 6.10 --0 (-0%)

Prev. Close

$6.10

Today 6M 1Y 5Y

Open

$6.10

52 Wk High

$45.34

52 Wk Low

$15.92

Day High

$6.10

Day Low

$6.10

P/E

2.62

EPS

$2.33

Volume

2,342

Friends, Peers and Foes (?): SOPH, STIM, TFX, ZOM, CTKB (more...)

ALERTS | RSS

Jul 2, 2026 09:05 AM New Large-Scale Meta-Analysis Demonstrates Strong Prognostic Performance of Myriad’s Prolaris® Biopsy Test in Localized Prostate Cancer
Jun 23, 2026 04:25 PM Form 4 MYRIAD GENETICS INC For: Jun 23 Filed by: Skovronsky Daniel
Jun 23, 2026 09:05 AM Myriad Genetics expands Precise MRD cancer test to three tumor types
Jun 23, 2026 09:05 AM Myriad Genetics Expands Availability of Precise MRD™ for Colorectal, Renal and Breast Cancers, Supported by New Publication
Jun 23, 2026 08:36 AM Myriad Genetics board member Skovronsky resigns
Jun 23, 2026 08:32 AM Form 8-K MYRIAD GENETICS INC For: Jun 17
Jun 12, 2026 06:06 PM Form 4 MYRIAD GENETICS INC For: Jun 11 Filed by: Raha Samraat S.
Jun 12, 2026 06:06 PM Form 4 MYRIAD GENETICS INC For: Jun 11 Filed by: Donnelly Brian J
Jun 10, 2026 10:50 AM TD Cowen notes short interest shifts in life science tools stocks
Jun 9, 2026 04:21 PM Form 4 MYRIAD GENETICS INC For: Jun 08 Filed by: Kumar Rashmi

Entities mentioned with MYGN

View All Entities